Technology
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Biogen, Inc.. United States. Announced Date 28/07/2023. Closed Date 26/09/2023. Deal value: $7300m. Biogen to Acquire Reata Pharmaceuticals. Industry: Biogen, Inc. is a biotechnology company specializing in the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases.